Drug Database · Food supplement

DIAMAXIN 600

Alpha-lipoic acid

Food supplement3 registrations
Company: ADP PHARMA CORPORATION; ELIXIR PHARMA INC Last updated: Audience: Licensed health professionals
Registered with the Philippine FDA as a FOOD SUPPLEMENT — no approved therapeutic claims. Not a substitute for prescribed treatment.

FDA Philippines registrations

3 current food-supplement registrations under the brand DIAMAXIN 600. Registration status changes; confirm a product's current status on the FDA verification portal using its FR number.

Verify on PH FDA portal

ALPHA LIPOIC ACID 600 MG FOOD SUPPLEMENT TABLET

Ingredients
  • Alpha-lipoic acid
As registered: ALPHA LIPOIC ACID 600 MG
FR number
FR-4000014566055 · verify on the FDA portal
Registered as
Food supplement
Form
Tablet
Company
ELIXIR PHARMA INC
Issued
May 11, 2026
Valid until
June 12, 2028
FDA risk class
High Risk
Application
Amendment

ALPHA LIPOIC ACID 600 MG FOOD SUPPLEMENT TABLET

Ingredients
  • Alpha-lipoic acid
As registered: ALPHA LIPOIC ACID 600 MG
FR number
FR-4000015971041 · verify on the FDA portal
Registered as
Food supplement
Form
Tablet
Company
ELIXIR PHARMA INC
Issued
July 21, 2026
Valid until
April 8, 2028
FDA risk class
High Risk
Application
Amendment

ALPHA LIPOIC ACID 600MG FOOD SUPPLEMENT TABLET

Ingredients
  • Alpha-lipoic acid
As registered: ALPHA LIPOIC ACID 600MG
FR number
FR-4000009173116 · verify on the FDA portal
Registered as
Food supplement
Form
Tablet
Company
ADP PHARMA CORPORATION
Issued
June 13, 2024
Valid until
March 6, 2027
FDA risk class
High Risk
Application
Amendment

Related drug pages

Registered drug products that share an ingredient with this supplement. A drug registration carries approved indications and labeling; a food supplement does not, and its content and quality are not verified in the same way.

For health professionals. Data come from the FDA Philippines food-product registration database and may lag behind the official record. A food-supplement registration means the product may be sold as food; it is not an approval of safety or efficacy for any disease. Not a substitute for clinical judgment.